PCOS: how the syndrome really affects fertility
Polycystic ovary syndrome: diagnostic criteria, why there are calls to rename it, its actual impact on fertility, inositol.
Read the articleAntagonist, long, short, mild: behind these terms lies the same principle. To mature several follicles at once and prevent them from ovulating too early.
When the clinic sends the ‘protocol’, many patients receive a table of dates, doses and drug names without any explanation. Understanding the logic helps to avoid mistakes and to ask the right questions if anything changes along the way.
The protocols differ mainly in how the second objective is achieved.
Stimulation begins on the 2nd or 3rd day of the period. Around the 5th or 6th day, or when the follicles reach approximately 13–14 mm, a GnRH antagonist (cetrorelix, ganirelix) is added, which immediately blocks ovulation. Treatment generally lasts 9 to 12 days until the trigger.
Its advantages: shorter duration, fewer injections, and, above all, a significantly lower risk of hyperstimulation, particularly as it allows an agonist trigger. ESHRE recommends it as the first-line protocol for most patients, with birth rates comparable to those of the long protocol.
The process begins by ‘resting’ the ovaries with a GnRH agonist (such as triptorelin), started during the luteal phase of the previous cycle, for around two weeks. Stimulation then begins. The whole process lasts three to four weeks.
It is still used in certain situations, for example in cases of endometriosis or to better schedule the date of egg retrieval. It takes longer and involves more injections.
The agonist is started at the same time as stimulation, to take advantage of its initial stimulating effect. It has been used in poor responders, although no superiority has been demonstrated; it is now less common.
Instead of an injectable antagonist, ovulation is suppressed using an oral progestogen (such as dydrogesterone or medroxyprogesterone). This is cheaper and simpler, but as the progestogen renders the endometrium unsuitable for implantation, all embryos are frozen and transferred at a later date. This strategy is common in egg donation (for the donor) and in egg freezing.
Lower doses, sometimes combined with letrozole or clomiphene citrate, or even no stimulation at all. Fewer eggs are obtained, but with less medication and at a lower cost. Useful for some poor responders or in cases where there are contraindications to hormone treatment. See poor response.
When the follicles are ready, an injection triggers final maturation:
The egg retrieval takes place 34 to 36 hours later; see the egg retrieval procedure.
For information on medicines and their prices in Greece, see this article.
For most patients, ESHRE recommends the antagonist protocol as the first-line option: it is shorter, carries a lower risk of hyperstimulation and has birth rates comparable to the long protocol.
With the antagonist protocol, there are generally 9 to 12 days of injections before the trigger. The long protocol lasts three to four weeks in total.
A stimulation in which ovulation is blocked by an oral progestogen rather than an injectable antagonist. All embryos are then frozen.
Call the clinic straight away, rather than doubling the dose on your own initiative.
The first consultation is free and without obligation.
Polycystic ovary syndrome: diagnostic criteria, why there are calls to rename it, its actual impact on fertility, inositol.
Read the articleFew eggs at retrieval: the Bologna and POSEIDON criteria, possible protocols (doses, DuoStim, accumulation), what doesn’t help.
Read the articleOvarian hyperstimulation syndrome (OHSS): who is at risk, warning signs, protocols that almost completely prevent it.
Read the articleClomiphene citrate, letrozole, gonadotropins: what each form of ovulation stimulation is used for, who it is suitable for, what the outcomes and risks are.
Read the article